The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
The five-minute survey includes questions on the number of otitis externa cases seen in practice, consultation times, common compliance issues, cytology uptake and client behaviour change frameworks.
Completed entries will be entered into a draw for a Fortnum & Mason hamper worth £100.
Charlotte Hill, brand manager at Dechra said: “The otitis externa in dogs survey will provide us with valuable insight into vets’ experiences of the condition.
"It will also allow us to identify any trends that may exist to help us improve how we as a profession approach otitis externa, while supporting owners when treating the condition which can be frustrating to manage.
https://forms.office.com/e/J7frrbL56A
Axiom Veterinary Laboratories and Woodley Equipment Company have announced a partnership which the companies say will mean they can offer a comprehensive solution encompassing referral laboratory services and in-house diagnostic testing, with significant cost savings for practices.
Steve Clarke, Business Development and Marketing Manager for Axiom said: "After an exhaustive search we believe that we have found a partner in Woodley that shares our drive and ambition in delivering a first class solution to practices along with service backup. We offer a cost-effective, quality service with flexibility, fast turnaround times including a free of charge courier service across many parts of the UK and Ireland. We believe that in the current economic climate it is an ideal time for practices to review both their referral laboratory service and their in-house equipment provision."
Mike Wickham, Managing Director of Woodley Equipment Company added: "We offer a wide range of equipment, tailored to the size of the practice, workload and specialty. In partnering with Axiom Veterinary Laboratories we are able to offer a complete package including exclusive and very competitive discount structures for practices.
Both companies with be exhibiting at the forthcoming WSAVA conference in Birmingham (Axiom stand 418 and Woodley Equipment Company stand 718).
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
Zoetis has announced that a batch of the bluetongue vaccines, Zulvac® 8 Bovis and Zulvac® 8 Ovis, is expected to become available to veterinary practices in mid-July, in time to manage the risk of an outbreak predicted by Defra to reach mainland UK by the late summer.
The company says the quantity of vaccine will not be unlimited and that it will strive to achieve as widespread availability as possible.
The two vaccines (Bovis for cattle and Ovis for sheep) are licensed to “prevent viraemia” caused by bluetongue virus serotype 8 (BTV-8). Prevention of viraemia, the presence of bluetongue virus in the blood, ensures no onward spread of infection via the blood sucking Culicoides midge.
The vaccines can be used in cattle from three months of age, or six weeks in sheep, requiring two doses three weeks apart in either species. Each dose is 2ml administered intramuscularly in cattle or subcutaneously in sheep, and onset of immunity is 25 days after the second dose. The vaccine provides immunity for a full 12 months.
The British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement from Zoetis, and another from MSD, but sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control. While it is good news that vaccine will be available, we know that both farmers and vets will have questions about cost and whether there will a limit to the amount of vaccine available in July. It would be helpful to have these questions clarified as soon as possible."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
For those new to the club, the idea is that every two weeks, we pick an article in Veterinary Practice and invite the author to join us on VetSurgeon.org, so that you can ask questions and discuss the subject with one another.
As a bonus, you can claim time spent reading or participating in the discussion towards your annual CPD requirement (press the claim CPD button at the top right of the discussion thread).
For this first discussion of 2023, author Andy Yale, an RCVS and European Veterinary Specialist in Small Animal Oncology and Lecturer in Veterinary Oncology at the RVC, will be joining us for a week to answer questions about 'Diagnosis and treatment of common canine oral tumours'.
To take part, first read Andy's article here: https://www.veterinary-practice.com/article/common-canine-oral-tumours.
Then come and join the VetSurgeon Clinical Article Club and post your questions or discussion points here: https://www.vetsurgeon.org/associations/vetsurgeon-clinical-article-club/
VetSurgeon.org Editor, Arlo Guthrie said: "I hope lots of you will come and join in. It really is a great opportunity to learn from specialists and from each other in a professional, moderated forum, where you can be confident of a friendly welcome.”
To find out about the RVC’s internationally recognised veterinary oncology team and the services it offers, visit: https://www.rvc.ac.uk/small-animal-vet/specialist-referrals/clinical-services/veterinary-oncology
Developed in conjunction with Fiona Lovatt BVSc PhD FHEA DSHP DipECSRHM FRCVS, past president of the Sheep Veterinary Society and RCVS-recognised specialist in sheep health and production, NoBACZ Navel disinfects and dries the navel in a couple of hours and seals with a colourful, natural resin that forms a long-lasting waterproof barrier to protect against bacterial ingress from the environment.
It can also be used on the area around ear tags in lambs and calves.
Nobacz Navel can be applied by dipping or spraying and contains a bitter agent to deter ewe or cow interference.
Fiona said: “Attention to detail is an essential component in the care of neonatal lambs.
"To reduce the risks of joint ill, shepherds need to do whatever they can to protect lambs from bacteria infecting either the navel or the ears at the point of tagging.
"This product has been carefully designed to both desiccate the area and to form a barrier to protect these vulnerable sites.
"I’ve seen it used successfully in a number of flocks now – both in late lambers from last year and early lambers from this.”
https://nobacz.com
Helen Ghosh, Defra's Permanent Secretary today confirmed the appointment of Nigel Gibbens as Chief Veterinary Officer (CVO). Nigel qualified as a veterinary surgeon in 1981 and has spent most of his career involved in animal health and welfare with lead roles on international trade and exotic diseases. Since 1990 he has held a variety of operational and advisory positions in the Government's veterinary and policy services. Nigel moved to the central animal health policy group in 1996 and worked on international trade for eight years, followed by surveillance and control of Bovine Spongiform Encephalopathy and animal welfare. He has also worked in general veterinary practice and for Government veterinary services in Belize and Yemen. He said: "I am delighted to have been appointed to this important and challenging role. I intend to build on the successes and lessons learned from recent exotic disease outbreaks to ensure that these risks continue to be managed as effectively as possible. "Defra and its Agencies must continue to work with animal keepers and the veterinary profession to deal with existing challenges such as Bluetongue and Tuberculosis, and to maintain good animal welfare standards and surveillance to identify and deal with any new threats. The Government will increasingly develop policy on disease control in partnership with key stakeholders and I am committed to ensuring that those decisions are founded on the best possible veterinary advice." Nigel's first event as CVO will be to represent the UK at the World Animal Health Organisation General Session in Paris from 25 to 30 May.
MSD Animal Health has launched FlockCheck 2012, its complimentary sheep diagnostic service that identifies whether enzootic abortion or toxoplasmosis is present in a client's flock.
FlockCheck 2012 requires vets to take blood samples from 6-8 aborting ewes. MSD says that at a time when many farmers are asking for veterinary diagnostic support to confirm or rule out potential Schmallenberg virus infection, it makes sense to investigate whether other diseases are present in the flock at the same time.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Based on the previous two years' FlockCheck data (2011 and 2010), on average over 86% of submitted samples tested positive for toxoplasmosis and more than 62% were positive for enzootic abortion. Around 43% of samples showed exposure to both diseases.
"With lamb prices still remaining buoyant it has never been more important to ensure farmers minimise lamb losses. The 2012 FlockCheck service allows vets to identify whether toxoplasmosis or enzootic abortion is the cause of any aborted lamb losses and provides a starting point for discussions around the value of vaccination programmes with Enzovax and Toxovax."
Vets are asked to submit unit blood samples with the new 2012 FlockCheck forms.
The RCVS and the BVA have announced the launch of Vet Futures, a jointly funded initiative designed to stimulate discussion about the future of the profession, and help its members prepare for and shape it.
The initiative will draw on the experience and insight of a wide range of individuals and organisations, including veterinary surgeons and nurses, veterinary bodies, farmers, pet owners and other key stakeholders.
The objective is to understand where the provision of veterinary services is currently heading, whether this is in the best interests of the profession, animal owners and the public at large, and what might be done to shape an optimal future for the veterinary team, keeping animal health and welfare at its heart.
In the project's first phase, independent researchers will gather evidence via focus groups, phone interviews and desk-based research, in addition to the gauging of opinion through events, the internet and social media.
This evidence gathering will be followed by an engagement phase, where the profession will be asked for their feedback on initial thoughts; a period of analysis, where a report will be written by the independent researchers; and, finally, there will be an action phase, where key strategic issues will be identified, together with a clear plan for action from the BVA and the RCVS, as well as other organisations and individuals.
Professor Stuart Reid, RCVS President. said: "The RCVS is implementing a programme of reform to make it a first-rate regulator, but how do we also make ours a first-rate profession, that is resilient and agile enough to meet future demands?
"The Vet Futures project will not just be about horizon-scanning, but getting a fix on those issues over the horizon that we may not yet have considered, such as the use of emerging technologies.
"It's an exciting challenge and I am looking forward to members of the veterinary team getting involved so that, together, we can develop an action plan that will deliver a sustainable future for the profession."
John Blackwell, BVA President, said: "It is no secret that the veterinary profession is changing rapidly and that is why the theme for my presidential year is 'driving change and shaping the future'. It is essential that we come together to map out where we want to be as a strong and trusted profession and identify how we can make that happen.
"On such cross-cutting issues it is appropriate that the two leading professional bodies come together to provide joint leadership for the profession, but we are keen to engage as many individuals and stakeholders as possible. It is designed to be a hugely collaborative project and we want to hear voices from across the whole profession and the whole veterinary team."
The project has a dedicated website www.vetfutures.org.uk where the latest events, reports and publications will be found. There will also be a 'topic of the month' for the duration of the project, with controversial opinion-pieces being posted to stimulate debate from within the profession and amongst animal owners and other stakeholders.
Dan Forster MRCVS and his wife Kirsty, a veterinary nurse, run The Mobile Vet Ltd, which offers a 24/7 mobile service to clients and their animals on the Isle of Wight. The team work out of custom-designed vehicles, as well as their fully equipped static veterinary clinic in Newport.
In launching The Mobile Vet, their vision was to create a mobile clinic which could provide all of the services normally provided in a traditional clinic rather than just some. The veterinary team uses the latest technology and veterinary software to communicate with clients and works from vehicles specifically designed by Dan and Kirsty.
The Queen’s Awards for Enterprise are awarded to businesses for outstanding achievement in International Trade, Innovation and Sustainable Development. Winners of the Innovation Awards are judged to have shown outstanding success as the result of an innovation.
Dan said: "We aim to offer a caring and professional service to Islanders and their pets while also maintaining a good work/life balance. We can do almost everything from our vehicles but, when necessary, we utilise our fully equipped static clinic. We aim to offer a highly professional veterinary service using state-of-the-art equipment, which is also convenient to our clients. We have recently introduced a CT scanning service and laparoscopic surgery to expand our clinical services further.
"We are honoured to receive this prestigious award and had a fantastic day. The Award would never have been achievable without the support of our wonderful team. We look forward to continuing to provide an exemplary level of service to our clients."
The company says it believes it is the first major veterinary business in the UK to make this promise.
As a result of the pledge, salaries for about a third of the pet emergency firm's 1280 employees, including receptionists and animal care assistants, are set to increase to at least £9.50 an hour from April.
Vets Now says it has made the pledge on the recommendation of the Living Wage Foundation, which offers independent advice to employers and says £9.30 is now the real cost of living, not the Government-set national living wage of £8.72 for people aged 25 and over.
Vets Now’s chief executive Mark Ross said: "Our people are our biggest asset and at the heart of everything we do. We want to properly recognise the vital role each and every one of them plays in the business.
"This move demonstrates our commitment to that. We are confident that by paying all of our staff a competitive hourly rate of at least 20p more than the real living wage we will achieve higher morale and lower turnover."
Animal care assistant, Jody Reynolds, who works in Vets Now out-of-hours clinic in Kirkcaldy, said: “It’s amazing that Vets Now has been able to increase salaries to not only meet but exceed the real living wage. The extra will really help towards the cost of everyday living and even allow a few luxuries."
In the most recent Petplan Pet Census, an annual study of pet ownership in the UK, 97% of vets reported that a lack of funds had led to owners choosing euthanasia over treatment.
Whilst some cases are the result of one-off ‘emergency' treatment, manageable long-term conditions are often at the root of much unnecessary euthanasia because owners simply cannot afford the cost of ongoing treatment. Reported increases in pet obesity and diabetes, arthritis and behavioural problems have all been cited in the Pet Census as common causes of increased and ongoing vet bills.
Vets have been reporting a rise in diseases that are related to obesity in companion animals for some time and with the Petplan Pet Census panel of almost two hundred (198) UK veterinary practices reporting that more than one third (36%) of all dogs and one quarter (29%) of cats they treat are obese, the future for many pets looks bleak. More than half (53%) of vets say that cases of cat and dog diabetes are on the increase. Obesity is actually bucking the trend of more historically significant diseases, including kennel cough and feline leukaemia, which are either remaining static or decreasing.
The number of pets with behavioural problems is also on the rise, with more than half of vets (55%) reporting an increase and most (95%) practices offering support for these animals. Effective treatment is not a quick-fix solution and requires changes to the owner's lifestyle and lengthy work with experts in the field.
Petplan Vet of the Year, Brian Faulkner said: "I think it is a common misconception that the predicament forcing pet owners to euthanase their pet is the out-of-the-blue, one-off vet fees for emergencies. But in fact we are noticing that owners whose pets have on-going illnesses such as diabetes and even behavioural problems that are very manageable are being faced with the dreadful decision to have to euthanase than face the ongoing financial burden. It's even more devastating when the owners have actually taken out an insurance policy but the nature of the policy only covers treatment of any one condition for up to one year. I always advise people to make sure their policies do not cap the time period over which any one condition is covered to avoid this very problem as more comprehensive insurers are then unable to offer cover on a pre-existing condition."
Simon Wheeler, Head of Marketing at Petplan, said: "We receive over 8,700 claims per week and of the top ten claims, six could be recurrent manageable conditions, such as diabetes or arthritis - the very animals that are currently most at risk of being euthanased."
Research announced simultaneously by Sainsbury's Finance has reached similar conclusions. Sainsbury's found that:
Sainsbury's believes that there are two main reasons for this tragic problem: advances in veterinary care leading to increased costs, and the large number (55%) of pets that remain uninsured.
Ed's note: Isn't it time that pet insurance became compulsory?
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
A survey conducted earlier this year by Novartis Animal Health1 has shown that owners of dogs diagnosed with atopic dermatitis want to learn more about the condition after their veterinary consultation.
When asked about what would help them understand and cope with their dog receiving a diagnosis of atopic dermatitis, 42% of dog owners said that they want reliable information about the condition on the Internet that they can read at their own pace. 27% said that hearing or reading about case studies of dogs that were diagnosed with atopic dermatitis would be a source of help and reassurance.
That isn't to take anything away from the importance of the relationship between owner and vet: 49% of respondents said that having enough time to discuss everything with their vet is the most important thing following a diagnosis of atopic dermatitis.
However, the reality of busy small animal practice means that some vets are apparently finding themselves short of time, with 62% saying that they would like to have more time in consultations to explain the diagnosis fully.
To support both vets and owners, Novartis has produced a range of education materials available at www.itchfreepet.co.uk. They include information about a variety of skin conditions in dogs and cats, including causes, clinical signs, diagnostics and treatment options, which can all be used to support recommendations made during consultations.
Novartis says it is also continuing to support vets with the 'Comfort Club' scheme, through which owners get the 2nd, 6th and 12th month of Atopica treatment free of charge. The club also allows clients to try other dermatology products that might help their pet's condition free of charge, including shampoo, EFA's and specialist diets.
Ricardo Garvao, category manager at Novartis said: "By providing reliable information and tools to help re-iterate and expand on the information given to owners by their vets, we hope to help both parties make the most of the face to face time that they have with each other. Ultimately this will strengthen the vet-client relationship, which can only improve long-term clinical outcomes.
"Good client education is vital, demonstrated by the fact that nearly a quarter (23 per cent) of pet owners that admit to giving up on their vet's advice claim that this is because they haven't understood it. A large part of the trust building process is being able to recommend a management strategy with proven efficacy and safety data for long-term use, such as Atopica. Atopica has been keeping dogs with atopic dermatitis comfortable for a decade due to its proven ability to safely provide long-term reduction of pruritus and skin lesions associated with the disease, as demonstrated by the recently published independent paper 'The use of ciclosporin: a decade of experience in veterinary dermatology."
Reference
Eukanuba's Longevity Council has published a new video in which the panel of experts offer their thoughts about how veterinary surgeons can educate clients about helping their pets grow old gracefully.
The video includes contributions from the following council members, discussing things like preventative medicine and the importance of good diet/body weight and exercise:
watch?v=JRjCWhnGaGY
Hand-mouldable into any shape, Hoof Repair is used to create prosthetic hoof extensions and additions that restore foot integrity.
The company says there is no exothermic reaction when the thermoplastic hardens, which eliminates issues caused by excessive heat and makes the product suitable for treating acute laminitis, cracked hooves and horses that have lost a lot of hoof.
When used with Imprint Structural Adhesive, Hoof Repair forms a bond with hoof wall which can be nailed into and rasped, and will stay in place as hoof grows. Hoof Repair is also suitable for treating foal foot deformities.
The company says Hoof Repair is often used in conjunction with Imprint shoes, which are made of the same low melt, long lasting thermoplastic. It allows extensions to be made to the shoes and together the Imprint system protects and supports the hoof allowing the foot to flex and move freely.
Andrew Poynton, Imprint’s Inventor said: "Hoof Repair forms part of a foot care system that has been developed over 20 years by farriers in association with veterinary surgeons. Hoof Repair assimilates hooves precisely to retain the foot integrity and it is particularly useful for treating acute laminitis and cracked or badly damaged hooves."
The new RCVS brand has been highly commended in the 'Brand Development' Category of the Membership Communication (MemCom) Awards.
The new look, which was launched last year, aimed to clarify the role and function of the College, with the strapline 'Setting veterinary standards' and a professional new livery of blue and gold.
The award was made at a presentation at the Institute of Directors on 17 May, and the judges' citation said: "[The rebrand] sought to overcome a remote and stuffy image whilst at the same time seeking to underline that it is the only Royal College that is primarily a regulatory body acting in the public interest," adding that "to put this into second place took a remarkable entry".
The top award in the category was taken by the Wildfowl and Wetland Trust, with its book 'Watching Waterbirds', endorsed by the TV celebrity Kate Humble.
Lizzie Lockett, RCVS Head of Communications said: "Design can be subjective but the important thing is what it communicates. We are delighted to have received this commendation in recognition of the work we have done to ensure the role of the College is clearer for both the public and the profession."
Norbrook has announced the launch of Spotinor Deltamethrin spot-on, a new product which kills a wide range of external parasites that can have economically damaging effects on cattle, sheep and lambs.
The product is effective against lice and flies on cattle, ticks, lice, keds and established blowfly strike on sheep, and lice and ticks on lambs. It is available in 250ml and 500ml squeeze neck dispensing packs as well as a 1 litre and 2.5 litre backpack with dosing gun. The dose is 10ml for cattle, 5ml for sheep and 2.5ml for lambs (under 10kg/1 month of age).
Spotinor has a zero milk withhold time.
Edward Haughey, Director of Norbrook GB, said: "As Britain's leading veterinary pharmaceutical company, Norbrook is committed to providing British farmers and vets with the products and services they need to manage animal health effectively. Spotinor is the first generic to market, which displays the same benefits as the pioneer product. We are delighted to launch Spotinor, which gives livestock producers a greater choice of safe and sound solutions for the control of external parasites."
For more information, contact your Norbrook representative, telephone +44 (0) 1536 741 147 or email: enquiries@norbrook.co.uk
The programme covers everything from diagnostic imaging and ophthalmic emergencies to using echocardiography to help with day-to-day decision-making in practice.
SCVS says the programme has been made possible by the addition of a new lecture theatre during SCVS’s recent expansion, which was supported by the hospital's owners IVC Evidensia.
Stephen Collins, SCVS Hospital Director and IVC Evidensia’s National Cardiology Lead, said: “We’re proud to announce one of the UK’s most comprehensive CPD programmes and share the vast knowledge that our specialist team has with the rest of the veterinary community.
“Our programme is packed full of informative and practical sessions that every vet can benefit from - whether that’s specialist skill development or improving everyday advice and practices in clinic.”
A full list of CPD events is available here: https://www.ivcevidensiareferrals.com/events-and-cpd.
www.scvetspecialists.co.uk
Vets should now consider Angiostrongylus vasorum a countrywide parasite and not one that is restricted to the traditional hotspots of the South East, the Midlands and south Wales. This was the main message delivered by Shelia Brennan of University College Dublin to almost 300 vets attending the recent Bayer-sponsored A vasorum CPD meetings, held across the north of England and Scotland.
Sheila said: "Until recently, angiostrongylosis was only recognised in limited areas of the UK, and confirmed cases were few and far between. Now we are hearing reports of the disease as far afield as Kent and Glasgow and dogs are dying as a result. If caught early enough, the disease can be treated successfully. Vets should be aware of the many and varied symptoms and consider this parasite as a differential in any dog with suspicious clinical signs."
Dogs of any age can be infected with the parasite, but the majority presenting with clinical disease are less than two years of age. A number of clinical presentations are recognised. Dogs may present with respiratory signs (cough, exercise intolerance), coagulopathy, neurological signs, syncope and in a small number of cases hypercalcaemia. These signs can occur in isolation or in combination, and not all dogs have respiratory signs. Haemorrhage following routine neutering has been anecdotally reported. Dogs with a history of eating the parasite's intermediate hosts (slugs and snails) should be considered as being at high risk.
Chris White, Bayer's Advocate product manager said: "The attendance of nearly 300 vets at the four-meeting series, in areas not normally associated with the disease, is further evidence that vets are becoming increasingly concerned about the threat posed by A vasorum. This is the third series of meetings we have held, reaching around 1,000 vets and vet nurses across the country."
The Association says that the qualification is intended to give vets the chance to conduct clinical research relating to their work – in particular vets working in general practice.
The qualification, validated by Nottingham Trent University, is aimed at people who already have any accredited Postgraduate Certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery.
The programme is based on a further 1,200 study hours and could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability.
Frances Barr, BSAVA Academic Director, has developed the most extensive CPD programme in the 60-year history of the organisation. She said: "It’s a really significant addition to the BSAVA CPD programme and another step supporting lifelong learning, which we hope will have a very positive impact on the profession."
"Anyone who has an interest in clinical research – such as evaluating risk factors for a particular disease or factors that might influence an outcome – will find this an ideal way to satisfy their enquiring mind.
"If they have the motivation to keep developing a deeper understanding, we can provide encouragement and support for how to answer those clinical questions."
The Masters programme starts with online study into the principles of clinical research, which students will then apply to their own research project.
Students will be allocated a ‘matched’ supervisor who will provide project advice and guidance, plus the BSAVA team will be on hand to ensure ongoing support and encouragement.
The programme starts in January 2017 and applications open this October.
Frances added: "It can sometimes be quite difficult to get going in research when you don’t know how to do it, so having taken the first step in a supported environment we hope many will go on to do extend their clinical research ambitions.
"BSAVA’s mission is to support vets at every stage of their careers. There are often limited opportunities for practitioners to conduct clinical research, so this is a qualification that enables vets to do just that."
For more information, please contact the BSAVA Education team at masters@bsava.com